Go to Page # Page of 45

Arrhythmias and Clinical EP Atrial Fibrillation: Contemporary Management Strategies

 Samuel Asirvatham MD, Enrique Melgarejo Rojas MD
  12th-Sep-2017
Description: I receive royalties for work licensed through Mayo Clinic to a privately held company for contributions related to the use of nerve signal modulation to treat central, autonomic and peripheral nervous system disorders, including pain. Mayo Clinic receives royalties and owns equity in this company. The company does not currently license or manufacture any drug or device in the medical field.
Views: 615
Domain: Medical
Category: Therapy
Maxims of Tech: Rules of Engagement for a Fast Changing Environment
Contents:
Arrhythmias and Clinical EP
Atrial Fibrillation:
Contemporary Management Strategies
Samuel Asirvatham, MD & Enrique Melgarejo Rojas, MD

Saturday, June 24, 2017
2:40 to 3:25 p.m.

AF Ablation and
The Impact on Clinical Practice

Samuel J. Asirvatham, M.D.
Mayo Clinic – Rochester

©2012 MFMER | 3200268v1(2003)-3

Disclosures
Relevant financial relationship(s) with industry
•I rec ... See more

Recent Presentations

...
23 November, 2017

Medical Student Summer Research Programs

Select a faculty sponsor With the help of your sponsor, draft a project proposal Complete the online application Demographic Information Name, address, GPA, MCAT Br

...
22 November, 2017

Genome Editing: How to Use CRISPR

Recommended! By default, sgRNA targets are designed using the NCBI reference sequence. A polymorphism could decrease or eliminate CRISPR activity.

Ed Davis PhD
21 November, 2017